UB Paderborn / Katalog / Suche / in CDI

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis

BMJ (Online), 2019-07, Vol.366, p.l4363

2019

Link zum Volltext

Verfügbarkeit prüfen

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

Thrombosis journal, 2013-09, Vol.11 (1), p.21-21

2013

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma

Clinical cancer research, 2019-07, Vol.25 (13), p.3772-3775

2019

Link zum Volltext

Verfügbarkeit prüfen

Paris-Trousseau thrombocytopenia is phenocopied by the autosomal recessive inheritance of a DNA-binding domain mutation in FLI1

Blood, 2015-10, Vol.126 (17), p.2027-2030

2015

Link zum Volltext

Verfügbarkeit prüfen

Risk of recurrent venous thromboembolism according to baseline risk factor profiles

Blood advances, 2018-04, Vol.2 (7), p.788-796

2018

Link zum Volltext

Verfügbarkeit prüfen

Serotonin Release Assay: Functional Assay for Heparin- and Vaccine-Induced (Immune) Thrombotic Thrombocytopenia

Methods in molecular biology (Clifton, N.J.), 2023, Vol.2663, p.463

2023

Link zum Volltext

Verfügbarkeit prüfen

Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration

Circulation (New York, N.Y.), 2014-09, Vol.130 (13), p.1062-1071

2014

Link zum Volltext

Verfügbarkeit prüfen

Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use

Blood, 2016-03, Vol.127 (11), p.1417-1425

2016

Link zum Volltext

Verfügbarkeit prüfen

Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis

BMJ open, 2017-09, Vol.7 (9), p.16950-16950

2017

Link zum Volltext

Verfügbarkeit prüfen

Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin

JAMA internal medicine, 2014-06, Vol.174 (6), p.947

2014

Link zum Volltext

Verfügbarkeit prüfen

Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE study

Thrombosis and haemostasis, 2015-08, Vol.114 (3), p.645

2015

Link zum Volltext

Verfügbarkeit prüfen

Platelet function testing in uraemic patients

Hematology (Luxembourg), 2008-02, Vol.13 (1), p.49-58

2008

Link zum Volltext

Verfügbarkeit prüfen

Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension

Chest, 2016-11, Vol.150 (5), p.1059-1068

2016

Link zum Volltext

Verfügbarkeit prüfen

Validation of whole blood impedance aggregometry as a new diagnostic tool for HIT: results of a large Australian study

Thrombosis and haemostasis, 2012-03, Vol.107 (3), p.575

2012

Link zum Volltext

Verfügbarkeit prüfen

Platelet-activating functional assay resolution in vaccine-induced immune thrombotic thrombocytopenia: differential alignment to PF4 ELISA platforms

Research and practice in thrombosis and haemostasis, 2023-03, Vol.7 (3), p.100128-100128, Article 100128

2023

Link zum Volltext

Verfügbarkeit prüfen

Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE

Chest, 2016-11, Vol.150 (5), p.1059-1068

2016

Link zum Volltext

Verfügbarkeit prüfen

The direct factor Xa inhibitor rivaroxaban

Medical journal of Australia, 2009-04, Vol.190 (7), p.379-383

2009

Link zum Volltext

Verfügbarkeit prüfen

The direct thrombin inhibitor melagatran/ximelagatran

Medical journal of Australia, 2004-10, Vol.181 (8), p.432-437

Brighton, Timothy A

2004

Link zum Volltext

Verfügbarkeit prüfen

Platelet activation in the hypertensive disorders of pregnancy

American journal of obstetrics and gynecology, 2002-09, Vol.187 (3), p.688-695

2002

Link zum Volltext

Verfügbarkeit prüfen

A Multi-Centre, Single-Arm, Open-Label Study Evaluating the Safety and Efficacy of Fixed Dose Rituximab in Patients with Refractory, Relapsing or Chronic Idiopathic Thrombocytopenic Purpura (R-ITP1000 Study) and Exploring Rituximab Response with the FcGammaR3A Polymorphisms

Blood, 2011-11, Vol.118 (21), p.1157-1157

2011

Link zum Volltext

Verfügbarkeit prüfen

Microheterogeneity of beta-2 glycoprotein I: implications for binding to anionic phospholipids

Biochemical journal, 1999-05, Vol.340 ( Pt 1) (1), p.59-67

1999

Link zum Volltext

Verfügbarkeit prüfen

Recent insights into antiphospholipid antibody-mediated thrombosis

Bailliere's best practice & research. Clinical haematology, 1999-09, Vol.12 (3), p.407-422

1999

Link zum Volltext

Verfügbarkeit prüfen

Microheterogeneity of beta-2 glycoprotein I: implications for binding to anionic phospholipids

Biochemical journal, 1999-05, Vol.340 (1), p.59-67

1999

Link zum Volltext

Verfügbarkeit prüfen

7 Antiphospholipid antibodies and thrombosis

Baillière's clinical haematology, 1994, Vol.7 (3), p.541-557

1994

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma

Paris-Trousseau thrombocytopenia is phenocopied by the autosomal recessive inheritance of a DNA-binding domain mutation in FLI1

Risk of recurrent venous thromboembolism according to baseline risk factor profiles

Serotonin Release Assay: Functional Assay for Heparin- and Vaccine-Induced (Immune) Thrombotic Thrombocytopenia

Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration

Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use

Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis

Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin

Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE study

Platelet function testing in uraemic patients

Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension

Validation of whole blood impedance aggregometry as a new diagnostic tool for HIT: results of a large Australian study

Platelet-activating functional assay resolution in vaccine-induced immune thrombotic thrombocytopenia: differential alignment to PF4 ELISA platforms

Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE

The direct factor Xa inhibitor rivaroxaban

The direct thrombin inhibitor melagatran/ximelagatran

Platelet activation in the hypertensive disorders of pregnancy

Determining the Rate of Anti-PF4 Antibody Positive Results in Patients Presenting with Venous Thrombosis but a Normal Platelet Count Following ChAdOx1 Ncov-19 Astrazeneca Vaccination: An Australian Combined State Testing Centre Experience

A Multi-Centre, Single-Arm, Open-Label Study Evaluating the Safety and Efficacy of Fixed Dose Rituximab in Patients with Refractory, Relapsing or Chronic Idiopathic Thrombocytopenic Purpura (R-ITP1000 Study) and Exploring Rituximab Response with the FcGammaR3A Polymorphisms

Microheterogeneity of beta-2 glycoprotein I: implications for binding to anionic phospholipids

Recent insights into antiphospholipid antibody-mediated thrombosis

Microheterogeneity of beta-2 glycoprotein I: implications for binding to anionic phospholipids

7 Antiphospholipid antibodies and thrombosis

Aktive Filter

Suchergebnisse filtern